Literature DB >> 19570688

Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis.

Joel Fleury Djoba Siawaya1, Novel N Chegou, Michel M van den Heuvel, Andreas H Diacon, Nulda Beyers, Paul van Helden, Gerhard Walzl.   

Abstract

Cytokines are involved in the mediation and regulation of immunity, inflammation, and haematopoiesis. Secretion patterns may reflect the pathology or etiology of different diseases. In an attempt to increase our understanding of immunopathology during different forms of tuberculosis, and identify potential biological markers that may differentiate between forms of tuberculosis, we investigated the levels of 29 cytokines and KL-6 in the plasma of HIV uninfected patients with active pulmonary tuberculosis (TB) without pleural effusions and in pleural TB with and without HIV-co-infection. Healthy individuals with latent Mycobacterium tuberculosis infection and patients with non-TB pleural effusions were used as controls, We showed that pleural TB patients had increased levels of markers associated with systemic inflammation compared to pulmonary TB (EGF, G-CSF, IL-1beta IL-6, IL-8, IL-10, MCP-1, MIP-1alpha, MIP-1beta, TNF-alpha and VEGF), whereas pulmonary TB patients without effusions had higher levels of factors involved in cell-mediated immunity (IL-12p40 and sCD40L). Plasma levels of cytokines may therefore contribute to biosignatures of diseases like TB but the data also highlight systemic differences between pulmonary TB, pleural TB and other form of pleural effusion diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570688     DOI: 10.1016/j.cyto.2009.05.016

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  31 in total

Review 1.  Clinical immunology and multiplex biomarkers of human tuberculosis.

Authors:  Gerhard Walzl; Mariëlle C Haks; Simone A Joosten; Léanie Kleynhans; Katharina Ronacher; Tom H M Ottenhoff
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-04       Impact factor: 6.915

2.  Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis.

Authors:  Alexandre S de Almeida; Christina T Fiske; Timothy R Sterling; Spyros A Kalams
Journal:  Clin Vaccine Immunol       Date:  2011-10-28

3.  Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.

Authors:  Francesca Conradie; Andrea S Foulkes; Prudence Ive; Xiangfan Yin; Katerina Roussos; Deborah K Glencross; Denise Lawrie; Wendy Stevens; Luis J Montaner; Ian Sanne; Livio Azzoni
Journal:  J Acquir Immune Defic Syndr       Date:  2011-11-01       Impact factor: 3.731

4.  T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis.

Authors:  Marcela Henao-Tamayo; Scott M Irwin; Shaobin Shang; Diane Ordway; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2011-04-29       Impact factor: 3.131

5.  Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation.

Authors:  Z Toossi; C S Hirsch; M Wu; H Mayanja-Kizza; J Baseke; B Thiel
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

Review 6.  Immunological biomarkers of tuberculosis.

Authors:  Gerhard Walzl; Katharina Ronacher; Willem Hanekom; Thomas J Scriba; Alimuddin Zumla
Journal:  Nat Rev Immunol       Date:  2011-04-08       Impact factor: 53.106

Review 7.  The immunology of tuberculosis: from bench to bedside.

Authors:  Keertan Dheda; Stephan K Schwander; Bingdong Zhu; Richard N van Zyl-Smit; Ying Zhang
Journal:  Respirology       Date:  2010-04       Impact factor: 6.424

8.  Abnormal immune responses in persons with previous extrapulmonary tuberculosis in an in vitro model that simulates in vivo infection with Mycobacterium tuberculosis.

Authors:  Christina T Fiske; Alexandre S de Almeida; Ayumi K Shintani; Spyros A Kalams; Timothy R Sterling
Journal:  Clin Vaccine Immunol       Date:  2012-06-06

9.  The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis.

Authors:  Léanie Kleynhans; Nelita Du Plessis; Nasiema Allie; Muazzam Jacobs; Martin Kidd; Paul D van Helden; Gerhard Walzl; Katharina Ronacher
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

10.  Diagnostic markers for tuberculosis ascites: a preliminary study.

Authors:  Rajpal S Kashyap; Sonali M Saha; Khushboo J Nagdev; Sanjeevani S Kelkar; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Biomark Insights       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.